Global Peptide Cancer Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

A peptide cancer vaccine is an immunotherapeutic approach used in the field of cancer treatment and prevention. It is designed to stimulate the body's immune system to recognize and attack cancer cells by targeting specific proteins or peptides that are unique to those cancer cells. The vaccine typically contains a selected peptide or a combination of peptides derived from tumor-associated antigens, which are substances present on cancer cells but not on normal healthy cells. By introducing these peptides into the patient's body, the vaccine aims to trigger an immune response that targets and destroys cancer cells while sparing healthy tissues. Peptide cancer vaccines are considered a personalized and targeted therapy, as they can be customized to a patient's specific cancer type, and they hold promise for various cancer treatments, including melanoma and certain types of breast, prostate, and lung cancers. Clinical research and development in this field continue to explore the potential of peptide cancer vaccines as a complementary approach to traditional cancer treatments like surgery, chemotherapy, and radiation therapy.

According to DIResearch's in-depth investigation and research, the global Peptide Cancer Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peptide Cancer Vaccine include Boston Biomedical, Ultimovacs, BrightPath Biotherapeutics, TapImmune, Immatics, Imugene, Sellas, Generex Biotechnology, VAXON Biotech, OncoTherapy Science, ISA Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peptide Cancer Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide Cancer Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Cancer Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Cancer Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peptide Cancer Vaccine Include:

Boston Biomedical

Ultimovacs

BrightPath Biotherapeutics

TapImmune

Immatics

Imugene

Sellas

Generex Biotechnology

VAXON Biotech

OncoTherapy Science

ISA Pharmaceuticals

Peptide Cancer Vaccine Product Segment Include:

ITK-1

GRN-1201

TPIV200

TPIV110

UV1

Galinpepimut-S

TARP 27-35

HER-Vaxx

Vx-001

Others

Peptide Cancer Vaccine Product Application Include:

Breast Cancer

Lung Cancer

Melanoma

Prostate Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Peptide Cancer Vaccine Industry PESTEL Analysis

Chapter 3: Global Peptide Cancer Vaccine Industry Porter's Five Forces Analysis

Chapter 4: Global Peptide Cancer Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Peptide Cancer Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Peptide Cancer Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Peptide Cancer Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Peptide Cancer Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Peptide Cancer Vaccine Product by Type

1.2.1 Global Peptide Cancer Vaccine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 ITK-1

1.2.3 GRN-1201

1.2.4 TPIV200

1.2.5 TPIV110

1.2.6 UV1

1.2.7 Galinpepimut-S

1.2.8 TARP 27-35

1.2.9 HER-Vaxx

1.2.10 Vx-001

1.2.11 Others

1.3 Peptide Cancer Vaccine Product by Application

1.3.1 Global Peptide Cancer Vaccine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Melanoma

1.3.5 Prostate Cancer

1.3.6 Others

1.4 Global Peptide Cancer Vaccine Market Revenue and Sales Analysis

1.4.1 Global Peptide Cancer Vaccine Market Size Analysis (2019-2030)

1.4.2 Global Peptide Cancer Vaccine Market Sales Analysis (2019-2030)

1.4.3 Global Peptide Cancer Vaccine Market Sales Price Trend Analysis (2019-2030)

1.5 Peptide Cancer Vaccine Market Development Status and Trends

1.5.1 Peptide Cancer Vaccine Industry Development Status Analysis

1.5.2 Peptide Cancer Vaccine Industry Development Trends Analysis

2 Peptide Cancer Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Peptide Cancer Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Peptide Cancer Vaccine Market Analysis by Regions

4.1 Peptide Cancer Vaccine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Peptide Cancer Vaccine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Peptide Cancer Vaccine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Peptide Cancer Vaccine Revenue Forecast by Region (2025-2030)

4.3 Global Peptide Cancer Vaccine Sales and Forecast Analysis (2019-2030)

4.3.1 Global Peptide Cancer Vaccine Sales and Market Share by Region (2019-2024)

4.3.2 Global Peptide Cancer Vaccine Sales Forecast by Region (2025-2030)

4.4 Global Peptide Cancer Vaccine Sales Price Trend Analysis (2019-2030)

5 Global Peptide Cancer Vaccine Market Size by Type and Application

5.1 Global Peptide Cancer Vaccine Market Size by Type

5.1.1 Global Peptide Cancer Vaccine Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Peptide Cancer Vaccine Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Peptide Cancer Vaccine Market Size by Application

5.2.1 Global Peptide Cancer Vaccine Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Peptide Cancer Vaccine Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Peptide Cancer Vaccine Market Size by Type

6.3.1 North America Peptide Cancer Vaccine Sales by Type (2019-2030)

6.3.2 North America Peptide Cancer Vaccine Revenue by Type (2019-2030)

6.4 North America Peptide Cancer Vaccine Market Size by Application

6.4.1 North America Peptide Cancer Vaccine Sales by Application (2019-2030)

6.4.2 North America Peptide Cancer Vaccine Revenue by Application (2019-2030)

6.5 North America Peptide Cancer Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Peptide Cancer Vaccine Market Size by Type

7.3.1 Europe Peptide Cancer Vaccine Sales by Type (2019-2030)

7.3.2 Europe Peptide Cancer Vaccine Revenue by Type (2019-2030)

7.4 Europe Peptide Cancer Vaccine Market Size by Application

7.4.1 Europe Peptide Cancer Vaccine Sales by Application (2019-2030)

7.4.2 ? Europe Peptide Cancer Vaccine Revenue by Application (2019-2030)

7.5 Europe Peptide Cancer Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Peptide Cancer Vaccine Market Size by Type

8.3.1 China Peptide Cancer Vaccine Sales by Type (2019-2030)

8.3.2 China Peptide Cancer Vaccine Revenue by Type (2019-2030)

8.4 China Peptide Cancer Vaccine Market Size by Application

8.4.1 China Peptide Cancer Vaccine Sales by Application (2019-2030)

8.4.2 China Peptide Cancer Vaccine Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Peptide Cancer Vaccine Market Size by Type

9.3.1 APAC (excl. China) Peptide Cancer Vaccine Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Peptide Cancer Vaccine Revenue by Type (2019-2030)

9.4 APAC (excl. China) Peptide Cancer Vaccine Market Size by Application

9.4.1 APAC (excl. China) Peptide Cancer Vaccine Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Peptide Cancer Vaccine Revenue by Application (2019-2030)

9.5 APAC (excl. China) Peptide Cancer Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Peptide Cancer Vaccine Market Size by Type

10.3.1 Latin America Peptide Cancer Vaccine Sales by Type (2019-2030)

10.3.2 Latin America Peptide Cancer Vaccine Revenue by Type (2019-2030)

10.4 Latin America Peptide Cancer Vaccine Market Size by Application

10.4.1 Latin America Peptide Cancer Vaccine Sales by Application (2019-2030)

10.4.2 Latin America Peptide Cancer Vaccine Revenue by Application (2019-2030)

10.5 Latin America Peptide Cancer Vaccine Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Peptide Cancer Vaccine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Peptide Cancer Vaccine Market Size by Type

11.3.1 Middle East & Africa Peptide Cancer Vaccine Sales by Type (2019-2030)

11.3.2 Middle East & Africa Peptide Cancer Vaccine Revenue by Type (2019-2030)

11.4 Middle East & Africa Peptide Cancer Vaccine Market Size by Application

11.4.1 Middle East & Africa Peptide Cancer Vaccine Sales by Application (2019-2030)

11.4.2 Middle East & Africa Peptide Cancer Vaccine Revenue by Application (2019-2030)

11.5 Middle East & Africa Peptide Cancer Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Peptide Cancer Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Peptide Cancer Vaccine Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Peptide Cancer Vaccine Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Peptide Cancer Vaccine Average Sales Price by Manufacturers (2020-2024)

12.2 Peptide Cancer Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Peptide Cancer Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Boston Biomedical

13.1.1 Boston Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Boston Biomedical Peptide Cancer Vaccine Product Portfolio

13.1.3 Boston Biomedical Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Ultimovacs

13.2.1 Ultimovacs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Ultimovacs Peptide Cancer Vaccine Product Portfolio

13.2.3 Ultimovacs Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 BrightPath Biotherapeutics

13.3.1 BrightPath Biotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 BrightPath Biotherapeutics Peptide Cancer Vaccine Product Portfolio

13.3.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 TapImmune

13.4.1 TapImmune Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 TapImmune Peptide Cancer Vaccine Product Portfolio

13.4.3 TapImmune Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Immatics

13.5.1 Immatics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Immatics Peptide Cancer Vaccine Product Portfolio

13.5.3 Immatics Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Imugene

13.6.1 Imugene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Imugene Peptide Cancer Vaccine Product Portfolio

13.6.3 Imugene Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Sellas

13.7.1 Sellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Sellas Peptide Cancer Vaccine Product Portfolio

13.7.3 Sellas Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Generex Biotechnology

13.8.1 Generex Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Generex Biotechnology Peptide Cancer Vaccine Product Portfolio

13.8.3 Generex Biotechnology Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 VAXON Biotech

13.9.1 VAXON Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 VAXON Biotech Peptide Cancer Vaccine Product Portfolio

13.9.3 VAXON Biotech Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 OncoTherapy Science

13.10.1 OncoTherapy Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 OncoTherapy Science Peptide Cancer Vaccine Product Portfolio

13.10.3 OncoTherapy Science Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 ISA Pharmaceuticals

13.11.1 ISA Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 ISA Pharmaceuticals Peptide Cancer Vaccine Product Portfolio

13.11.3 ISA Pharmaceuticals Peptide Cancer Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Peptide Cancer Vaccine Industry Chain Analysis

14.2 Peptide Cancer Vaccine Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Peptide Cancer Vaccine Typical Downstream Customers

14.4 Peptide Cancer Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support